Impact of Insulin Resistance on Silent and Ongoing Myocardial Damage in Normal Subjects: The Takahata Study

Table 5

Comparisons of clinical characteristics of patients with and without IR and Mets in female.

	IR (−)	IR (+)	Mets (+)
Age (years)	62 ± 10	62 ± 10	64 ± 8
BMI (kg/m^2)	22.0 ± 3.0	24.5 ± 3.4*	26.4 ± 2.7^*#
sBP (mm Hg)	130 ± 16	135 ± 15*	144 ± 12^*#
dBP (mm Hg)	75 ± 9	78 ± 9*	83 ± 8^*#
BNP (pg/mL)	23.3 (14.0–37.0)	18.5 (10.8–30.5)*	19.8 (10.7–38.0)*
TC (mg/dL)	204 (185–223)	209 (190–232)*	212 (192–237)*
TG (mg/dL)	79 (62–102)	100 (76–123)*	166 (149–186)^*#
HDLc (mg/dL)	64 ± 14	61 ± 13*	48 ± 11^*#
LDLc (mg/dL)	127 ± 28	133 ± 29*	132 ± 29*
eGFR (mL/min/1.73 m^2)	107 (98–126)	104 (96–123)	101 (86–121)*
H-FABP (ng/mL)	3.3 (2.5–4.4)	3.6 (2.6–4.8)*	3.5 (2.7–5.2)*

BMI: body mass index; BNP: brain natriuretic peptide; TC: total cholesterol; TG: triglyceride; HDLc: high density lipoprotein cholesterol; LDLc: low density lipoprotein cholesterol; H-FABP: heart type fatty acid binding protein; sBP: systolic blood pressure; dBP: diastolic blood pressure; Data are presented as mean ± S.D or median (interquartile range). *P < 0.05 versus IR (−); ^#P < 0.05 versus IR (+).